Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00835796 · ClinicalTrials.gov registry record · Phase 1
Finasteride 5 mg Tablets, Non-fasting
A Phase 1 study, sponsored by Teva Pharmaceuticals USA.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT00835796: Completed Phase 1 study, sponsored by Teva Pharmaceuticals USA.
NCT00835796 is a Phase 1 study that has completed, run by Teva Pharmaceuticals USA. The registered enrollment target is 20 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00835796, a Phase 1 study, has completed, sponsored by Teva Pharmaceuticals USA.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
The objective of this study is to compare the relative bioavailability of finasteride 5 mg tablets (manufactured and distributed by TEVA Pharmaceuticals USA) with that of PROSCAR® 5 mg tablets (Merck) in healthy, adult, non-smoking, male subjects under non-fasting conditions.
Primary Outcome
Bioequivalence based on Cmax
Interventions
- DRUG Finasteride 5 mg tablets
- DRUG PROSCAR® 5mg tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2002-06 |
| Est. Completion | 2002-07 |
| Phase | Phase 1 |
What the finished NCT00835796 record still lists
NCT00835796 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 2 interventions - of which Finasteride 5 mg tablets is the first listed.
NCT00835796 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00835796 about?
NCT00835796 is a clinical study titled "Finasteride 5 mg Tablets, Non-fasting". The objective of this study is to compare the relative bioavailability of finasteride 5 mg tablets (manufactured and distributed by TEVA Pharmaceuticals USA) with that of PROSCAR® 5 mg tablets (Merck) in healthy, adult, non-smoking, male subjects under non-fasting conditions.
What is the current status of trial NCT00835796?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2002-06. Estimated completion is 2002-07.
What interventions are being tested in trial NCT00835796?
The interventions under investigation include: Finasteride 5 mg tablets (DRUG), PROSCAR® 5mg tablets (DRUG).
Who is sponsoring clinical trial NCT00835796?
This trial is sponsored by Teva Pharmaceuticals USA, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00835796's enrollment target sits among peer trials
20 1629th of 2000 higher than 285 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia